Model to predict the risk of cardiac death based on clinical characteristics and Gated-SPECT parameters

Grethel Rodríguez Cabalé1, Eduardo Rodríguez Cabalé2, Virginia Pubul Núñez3

  • 1Especialista en Medicina Interna, Hospital General de Granollers, Barcelona, Spain.

Insights

This study found that male sex, peripheral artery disease, diabetes, and specific gated-SPECT parameters like reduced ejection fraction predict cardiac death. A predictive model combining clinical factors and imaging results demonstrated high accuracy in assessing cardiac death risk.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Predictive Analytics

Background:

  • Coronary artery disease (CAD) is a leading cause of mortality.
  • Electrocardiogram-synchronized single-photon emission computed tomography (gated-SPECT) myocardial perfusion imaging is crucial for CAD diagnosis and staging.
  • Predicting adverse events requires integrating clinical data with imaging parameters, an area with limited research.

Purpose of the Study:

  • To investigate the relationship between clinical characteristics and gated-SPECT parameters with cardiac death.
  • To develop a predictive model for cardiac death risk using these combined factors.

Main Methods:

  • An observational, longitudinal, retrospective study of 2,230 patients with suspected CAD.
  • Collected data included clinical characteristics, gated-SPECT parameters, and cardiac death events.
  • Logistic regression modeling was employed to analyze variable relationships and predict cardiac death probability.

Main Results:

  • Male sex, peripheral arterial disease, and diabetes mellitus were associated with increased cardiac death risk.
  • Gated-SPECT parameters such as low ejection fraction (EF < 50%), increased left ventricular end-diastolic volume (VTD ≥ 140 ml), and enlarged ventricular size (VTS ≥ 70 ml) significantly predicted cardiac death.
  • The developed logistic regression model exhibited excellent predictive performance (AUC = 0.9656).

Conclusions:

  • Clinical factors and gated-SPECT parameters are significant predictors of cardiac death in patients with suspected CAD.
  • The developed model effectively predicts cardiac death risk, offering valuable insights for patient management and risk stratification.
Abstract

Related Concept Videos

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
333
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
490
Pharmacodynamic Models: Overview01:27

Pharmacodynamic Models: Overview

Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...
159
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
97
Actuarial Approach01:20

Actuarial Approach

The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
384